Intellectual Property India Publishes Patent Application for 'Lisdexamfetamine Dimesylate Orodispersible Tablet And Process For Preparation Thereof' Filed by Athena Pharmaceutiques Sas

MUMBAI, India, Nov. 14 -- Intellectual Property India has published a patent application (202411025463 A) filed by Athena Pharmaceutiques Sas, Louveciennes, France, on March 28, 2024, for 'lisdexamfetamine dimesylate orodispersible tablet and process for preparation thereof.'

Inventor(s) include Mahendra Baliram Chaudhari; Omprakash Doulatram Chandwani; Nitin Pandharinath Nehete; Amol Yuvraj Chaudhari; and Anita Kunal Shahane.

The application for the patent was published on Nov. 14, under issue no. 46/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure relates to a lisdexamfetamine dimesylate orodispersible tablet and a process for preparation thereof. The lisdexamfetamine dimesylate orodi...